SCHEMBL7197232

SCHEMBL7197232

COc1cc(C=CC(=O)c2ccccc2)c(N)c(OC)c1N

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.63
MAPT P10636 2/20 0.63
RAB9A P51151 2/20 0.63
LMNA P02545 1/20 0.63
BCHE P06276 1/20 0.63
ALDH1A1 P00352 1/20 0.60
SMN1; SMN2 Q16637 1/20 0.60
NLRP3 Q96P20 1/20 0.60
ABCG2 Q9UNQ0 2/20 0.57
TNFRSF1A P19438 1/20 0.56
CA1 P00915 1/20 0.53
CA2 P00918 1/20 0.53
KRAS P01116 1/20 0.53
MAOB P27338 2/20 0.52
ABCB1 P08183 2/20 0.52
NR1H4 Q96RI1 1/20 0.52
CYP1A1 P04798 1/20 0.51
CYP1A2 P05177 1/20 0.51
CYP2D6 P10635 1/20 0.51
CYP1B1 Q16678 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4864059 0.83 NPC1 (0.67) NPC1MAPTRAB9ALMNABCHE
SCHEMBL5313684 0.81 NPC1 (0.63) NPC1MAPTRAB9ALMNABCHE
SCHEMBL28126221 0.81 NPC1 (0.63) NPC1MAPTRAB9ALMNABCHE
SCHEMBL27762381 0.81 NPC1 (0.63) NPC1MAPTRAB9ALMNABCHE
SCHEMBL27923020 0.81 NPC1 (0.63) NPC1MAPTRAB9ALMNABCHE
SCHEMBL27391382 0.79 NPC1 (0.60) NPC1MAPTRAB9ALMNABCHE
SCHEMBL31059038 0.79 NPC1 (0.60) NPC1MAPTRAB9ALMNABCHE
SCHEMBL27391381 0.79 NPC1 (0.60) NPC1MAPTRAB9ALMNABCHE
SCHEMBL1764954 0.79 ABCG2 (0.86) NPC1MAPTRAB9ALMNABCHE
SCHEMBL4026900 0.79 LMNA (0.78) NPC1MAPTRAB9ALMNABCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030065039-A1 Biologically active 1,3-bis-aromatic-prop-2-en-1-ones, 1,3-bis-aromatic-propan-1-ones, and 1,3-bis-aromatic-prop-2-yn-1-ones STATENS SERUM INSTITUTE (DK) 2003-04-03 US disclosed
EP-0996432-A2 BIOLOGICALLY ACTIVE 1,3-BIS-AROMATIC-PROP-2-EN-1-ONES, 1,3-BIS-AROMATIC-PROPAN-1-ONES, AND 1,3-BIS-AROMATIC-PROP-2-YN-1-ONES STATENS SERUMINSTITUT (DK) 2000-05-03 EP disclosed
WO-1999000114-A2 BIOLOGICALLY ACTIVE 1,3-BIS-AROMATIC-PROP-2-EN-1-ONES, 1,3-BIS-AROMATIC-PROPAN-1-ONES, AND 1,3-BIS-AROMATIC-PROP-2-YN-1-ONES STATENS SERUM INSTITUT (DK) 1999-01-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030065039-A1 Biologically active 1,3-bis-aromatic-prop-2-en-1-ones, 1,3-bis-aromatic-propan-1-ones, and 1,3-bis-aromatic-prop-2-yn-1-ones AKR1C3, AKR1C1, AKR1A1 NPC1 3105/4885MAPT 3817/4885RAB9A 3774/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.